Phase 2 AML (Acute Myeloid Leukemia) Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Ivosidenib as Maintenance Therapy in Transplant-Ineligible IDH1-mutated AML and HR-MDS
MDS (Myelodysplastic Syndrome)AML (Acute Myeloid Leukemia)
Ruijin Hospital20 enrolled1 locationNCT07607418
Recruiting
Phase 2
VA-CIG Regimen for Previously Untreated Acute Myeloid Leukemia: A Multicenter Prospective Single-Arm Trial
AML (Acute Myeloid Leukemia)
Beijing 302 Hospital48 enrolled1 locationNCT07514832
Recruiting
Phase 2
Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML
AML (Acute Myeloid Leukemia)Allogeneic Hematopoietic Cell Transplantation (HCT)
Institute of Hematology & Blood Diseases Hospital, China134 enrolled5 locationsNCT07304232
Recruiting
Phase 2
Gilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive Treatment
AML (Acute Myeloid Leukemia)
Technische Universität Dresden60 enrolled1 locationNCT06696183